Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system

W Wei Mao J Junyan Jiang Y Yanping Xia L Lin Zhang

Article Details

Volume / Issue Vol. 15, Issue 1
Published January 24, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (4)

W

Wei Mao

J

Junyan Jiang

Y

Yanping Xia

L

Lin Zhang